Friday, July 10, 2026

Drug profile · INN

amorolfine

amorolfine (LOCERYL) is an FDA-listed pharmaceutical active ingredient. Associated with Galderma Australia Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — amorolfine

Quick answer

amorolfine (LOCERYL) is an FDA-listed pharmaceutical active ingredient. Associated with Galderma Australia Pty Ltd.

Key facts

INN amorolfine
Brand LOCERYL

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. ATM Phase 2 · BRIGHT MINDS BIOSCIENCES · Dual Diagnosis
  2. CaPre (TM) Phase 2 · Grace Therapeutics · Hypertriglyceridemia
  3. G-Pen(TM) 1 mg Phase 2 · Xeris Biopharma Holdings · Hypoglycemia
  4. TREAT LMNA Phase 2 · Sana Biotechnology · Laminopathies
  5. Kang Guan Recipe (Treat) Phase 1 · Chinese Academy of · Coronavirus Disease 2019
  6. A+ HA(tm) Unknown · Chinese Academy of · Knee Osteoarthritis

Frequently asked questions

What is amorolfine?

amorolfine (LOCERYL) is an FDA-listed pharmaceutical active ingredient. Associated with Galderma Australia Pty Ltd.

What is the brand name for amorolfine?

LOCERYL is a marketed brand name for amorolfine. Check FDA Drugs@FDA for the current US label holder and prescribing information.